TERAPIA CELULAR Y MEDICINA REGENERATIVA
Hebrew University of Jerusalem
Jerusalén, IsraelHebrew University of Jerusalem-ko ikertzaileekin lankidetzan egindako argitalpenak (1)
2022
-
MDS-110 SELECT-MDS-1 Trial in Progress: A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study of Tamibarotene/Azacitidine Versus Placebo/Azacitidine in Newly Diagnosed Adult Patients Selected for RARA-Positive Higher-Risk MDS
Clinical Lymphoma, Myeloma and Leukemia, Vol. 22, pp. S303-S304